Summary | |
---|---|
Symbol | LGALS3BP |
Name | lectin, galactoside-binding, soluble, 3 binding protein |
Aliases | MAC-2-BP; 90K; BTBD17B; TANGO10B; M2BP; gp90; CyCAP; L3 antigen; Mac-2-binding protein; serum protein 90K; t ...... |
Chromosomal Location | 17q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Secreted Secreted, extracellular space, extracellular matrix |
Domain |
PF07707 BTB And C-terminal Kelch PF00530 Scavenger receptor cysteine-rich domain |
Function |
Promotes integrin-mediated cell adhesion. May stimulate host defense against viruses and tumor cells. |
Biological Process |
GO:0002576 platelet degranulation GO:0006887 exocytosis GO:0006898 receptor-mediated endocytosis GO:0006968 cellular defense response GO:0045055 regulated exocytosis |
Molecular Function |
GO:0005044 scavenger receptor activity GO:0038024 cargo receptor activity |
Cellular Component |
GO:0005578 proteinaceous extracellular matrix GO:0030141 secretory granule GO:0031089 platelet dense granule lumen GO:0031983 vesicle lumen GO:0034774 secretory granule lumen GO:0042827 platelet dense granule GO:0060205 cytoplasmic membrane-bounded vesicle lumen GO:0072562 blood microparticle GO:0099503 secretory vesicle |
KEGG | - |
Reactome |
R-HSA-109582: Hemostasis R-HSA-76002: Platelet activation, signaling and aggregation R-HSA-114608: Platelet degranulation R-HSA-76005: Response to elevated platelet cytosolic Ca2+ |
Summary | |
---|---|
Symbol | LGALS3BP |
Name | lectin, galactoside-binding, soluble, 3 binding protein |
Aliases | MAC-2-BP; 90K; BTBD17B; TANGO10B; M2BP; gp90; CyCAP; L3 antigen; Mac-2-binding protein; serum protein 90K; t ...... |
Chromosomal Location | 17q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between LGALS3BP and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
Literatures describing the relation between LGALS3BP and anti-tumor immunity in human cancer.
|
Summary | |
---|---|
Symbol | LGALS3BP |
Name | lectin, galactoside-binding, soluble, 3 binding protein |
Aliases | MAC-2-BP; 90K; BTBD17B; TANGO10B; M2BP; gp90; CyCAP; L3 antigen; Mac-2-binding protein; serum protein 90K; t ...... |
Chromosomal Location | 17q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of LGALS3BP in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | LGALS3BP |
Name | lectin, galactoside-binding, soluble, 3 binding protein |
Aliases | MAC-2-BP; 90K; BTBD17B; TANGO10B; M2BP; gp90; CyCAP; L3 antigen; Mac-2-binding protein; serum protein 90K; t ...... |
Chromosomal Location | 17q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of LGALS3BP in various data sets.
|
Points in the above scatter plot represent the mutation difference of LGALS3BP in various data sets.
|
Summary | |
---|---|
Symbol | LGALS3BP |
Name | lectin, galactoside-binding, soluble, 3 binding protein |
Aliases | MAC-2-BP; 90K; BTBD17B; TANGO10B; M2BP; gp90; CyCAP; L3 antigen; Mac-2-binding protein; serum protein 90K; t ...... |
Chromosomal Location | 17q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of LGALS3BP. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | LGALS3BP |
Name | lectin, galactoside-binding, soluble, 3 binding protein |
Aliases | MAC-2-BP; 90K; BTBD17B; TANGO10B; M2BP; gp90; CyCAP; L3 antigen; Mac-2-binding protein; serum protein 90K; t ...... |
Chromosomal Location | 17q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of LGALS3BP. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by LGALS3BP. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | LGALS3BP |
Name | lectin, galactoside-binding, soluble, 3 binding protein |
Aliases | MAC-2-BP; 90K; BTBD17B; TANGO10B; M2BP; gp90; CyCAP; L3 antigen; Mac-2-binding protein; serum protein 90K; t ...... |
Chromosomal Location | 17q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of LGALS3BP. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | LGALS3BP |
Name | lectin, galactoside-binding, soluble, 3 binding protein |
Aliases | MAC-2-BP; 90K; BTBD17B; TANGO10B; M2BP; gp90; CyCAP; L3 antigen; Mac-2-binding protein; serum protein 90K; t ...... |
Chromosomal Location | 17q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of LGALS3BP expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | LGALS3BP |
Name | lectin, galactoside-binding, soluble, 3 binding protein |
Aliases | MAC-2-BP; 90K; BTBD17B; TANGO10B; M2BP; gp90; CyCAP; L3 antigen; Mac-2-binding protein; serum protein 90K; t ...... |
Chromosomal Location | 17q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between LGALS3BP and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | LGALS3BP |
Name | lectin, galactoside-binding, soluble, 3 binding protein |
Aliases | MAC-2-BP; 90K; BTBD17B; TANGO10B; M2BP; gp90; CyCAP; L3 antigen; Mac-2-binding protein; serum protein 90K; t ...... |
Chromosomal Location | 17q25 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting LGALS3BP collected from DrugBank database. |
There is no record. |